Your browser doesn't support javascript.
loading
Effects of recombinant human erythropoietin on angiogenesis in chronic ischemic porcine myocardium / 中华外科杂志
Chinese Journal of Surgery ; (12): 366-369, 2014.
Article in Chinese | WPRIM | ID: wpr-314696
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect and mechanism of recombinant human erythropoietin (rhEPO) on angiogenesis in chronic ischemic porcine myocardium.</p><p><b>METHODS</b>A ameroid constrictor was placed around the proximal circumflex branch of the left coronary artery in 12 Bama miniatures' swine artery by thoracoscopy. Electrocardiogram and coronary angiography were used to confirm the establishment of myocardial ischemia. The animals were divided into rhEPO treatment group (n = 6) and negative control group (n = 6). Treatment group received subcutaneous injection of rhEPO at 1, 3, 7, 14, 21 days, control group received saline. The expression of vascular endothelial growth factor (VEGF) in serum was assessed by ELISA. Ultrasonography and coronary angiography were assessed 28 days after therapy. Western blot was used to detect the expression of VEGF, phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal regulated kinases (p-Erk). The degree of angiogenesis was assessed by immunohistochemical analysis.</p><p><b>RESULTS</b>Serum VEGF rose significantly in both control and treatment groups, peaking at 3 days and then returning to the near-baseline level at 28 days, but the two groups showed no significant difference at each time point (P > 0.05). Echocardiographic measurements showed that the left ventricular systolic function of animals in treatment group increase significantly after rhEPO therapy. the expression levels of VEGF, p-Akt and p-Erk had markedly increased, which resulted in a 2.5-fold increased of VEGF, 1.1-fold increased of p-Akt, 1.5-fold increased of p-Erk (t = 37.721, 10.907, 12.957, all P = 0.000). there were significant increase in capillary density and arteriole density in the two groups ((944 ± 98) %/mm² vs. (569 ± 102) %/mm², (73 ± 13) %/mm² vs. (45 ± 10) %/mm², t = 4.214, 2.869, P = 0.016, 0.023).</p><p><b>CONCLUSIONS</b>rhEPO can promote angiogenesis and arteriogenesis and improve the left ventricular systolic function in porcine model of chronic myocardial ischemia. The potential mechanism is to up-regulated the expression of p-Akt and p-Erk.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Pathology / Pharmacology / Swine / Swine, Miniature / Recombinant Proteins / Erythropoietin / Myocardial Ischemia / Neovascularization, Physiologic / Vascular Endothelial Growth Factor A / Extracellular Signal-Regulated MAP Kinases Type of study: Prognostic study Limits: Animals / Humans / Male Language: Chinese Journal: Chinese Journal of Surgery Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pathology / Pharmacology / Swine / Swine, Miniature / Recombinant Proteins / Erythropoietin / Myocardial Ischemia / Neovascularization, Physiologic / Vascular Endothelial Growth Factor A / Extracellular Signal-Regulated MAP Kinases Type of study: Prognostic study Limits: Animals / Humans / Male Language: Chinese Journal: Chinese Journal of Surgery Year: 2014 Type: Article